Aop Health chooses Pisa as its Italian headquarters – Cronaca
Pisa, 20 May 2022 – The city of Pisa is further enriched. Yesterday it was inaugurated in Montacchiello la Italian branch of Aop Salute , an Austrian company pioneer in solutions and drugs for rare diseases and intensive care. In addition to the top management, the Pisan institutions were also present. Founded in Vienna in 1996 today the company pharmaceutical is present in addition 20 countries with a total of over 450 employees it’s a sales than in 2021 arrived a 163 million euros . And now, Pisa has been chosen precisely as a reference point in Italy.
“Pisa is a city of science, very salable abroad – he declared Nicola Zancan , General Manager of Aop Health in Italy -. Geography, infrastructures, and above all universities, are his points of reference, and together they create what I like to call the “osmotic process”. Our first goal is to raise awareness of the innovative therapies we have developed, and to make them available to patients. We are therefore proud to be able to offer these solutions “.
Directly from Austria, he was also present at the inauguration Giorgio Fischer , managing director of the Aop group. Here are his words:
“We are delighted to open this new location. Welcome! Aop Health has over 25 years of experience in developing innovative disease management solutions and making these solutions available over the long term. We invest approximately 20% of our turnover. in research and development every year, to ensure we reach patients with rare diseases or in critical condition. “
The Aop portfolio has about 30 products, and is diversified in the areas of onco-haematology, cardiology and pulmonology, in intensive care, in the neurological area and in that relating to metabolic disorders.
Representing the Common the commissioner for production and trade was present, Paolo Pesciatino I who declared: “We welcome Aop Health, a large international pharmaceutical company, to our city. Pisa, with its universities, can guarantee medical and scientific knowledge”.
“Good luck to Aop for this new adventure, may it be a story of great achievements!”, Are the words instead of Riccardo Palmisano national president of AssoBiotec.
The group of pharmaceutical knowledge, the top management, aims to achieve 1 million euros in turnover by 2030 worldwide, and in this context of growth, Italy and Pisa will play a leading role. In fact, the company aims to expand its staff, and is preparing to include in the near future people with a strong sense of ethics and responsibility, who possess all the professional skills. And Pisa, for its part, has what it takes to offer a valid scientific offer.
by Edoardo Greco